Carregant...
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection
Respiratory and gastrointestinal symptoms are the predominant clinical manifestations of the coronavirus disease 2019 (COVID-19). Infecting intestinal epithelial cells, the severe acute respiratory syndrome coronavirus-2 may impact on host's microbiota and gut inflammation. It is well establish...
Guardat en:
| Publicat a: | Chemotherapy |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
S. Karger AG
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089442/ https://ncbi.nlm.nih.gov/pubmed/33756475 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000515344 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|